Antibacterial Haemostatic Gels Market size is expected to reach USD 3 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of antibacterial haemostatic gels was USD 1 Billion. The increase in surgical techniques across the world will primarily drive the antibacterial haemostatic gels market In many of these conditions, the use of surgical and anesthesia care is required, making up a functional, adaptable, and resilient health system. The demand for surgical services in these regions will increase significantly from now until 2030 due to the significant increase in the incidence of cancer, road traffic accidents, and cardiovascular and metabolic diseases in LMICs. The practice of performing manual operations, or surgery, has a rich history dating back to antiquity.
Another reason that will propel the market of antibacterial haemostatic gels by the end of 2036 is the increasing prevalence of wound infection globally. Globally, between 9.1 and 26.1 million people are affected by FUs each year. A recent report raises the population's estimate to 40 to 60 million, citing various factors, including the DFU definition, the surveillance approach, and wound care access. The rise in bacterial resistance to antibiotics is likely to cause an increase in the burden of chronic wound infections worldwide. More than 6.5 million chronic wounds with evidence of bacterial infection are identified annually in the United States of America alone. In addition, several studies have identified the polymicrobial environment as a risk factor for the development of resistance to several antibiotics, including the third-generation cephalosporins used in the Mbarara Regional Referral Hospital for chronic wound infections.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
∼6% |
|
Base Year Market Size (2023) |
~USD 1 Billion |
|
Forecast Year Market Size (2036) |
~USD 3 Billion |
|
Regional Scope |
|
Product Type (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices)
The urinanalysis testing kits segment will grow the most by the forecast period and will hold almost 38% in the antibacterial haemostatic gels market because of modifying the efficiency, user-friendliness, and patient results. For instance, laboratories 'daily operations heavily rely on single-use plastics, and laboratory testing consumables are typically not susceptible to substitution. To ensure the safety and efficacy of testing protocols as well as the accuracy and reliability of data, laboratories are subject to stringent scientific and regulatory regulations. Life sciences research requires high-quality laboratory consumables, reagents, and validated standard processes. The life science sector has seen an unprecedented need for laboratory supplies related to COVID-19 laboratory work since the pandemic. With suppliers unable to keep up with demand, lab plastic consumables were being used at a faster rate than they were to run RT-PCR tests (consumables like plates and pipette tips). Therefore, this segment will hold immense importance in the transplant monitoring kits market.
End-Use Industry (Homecare, Diagnostic Centres, Hospitals, Clinics)
The hospital segment will have superior growth during the forecast period. It will hold around 50% of the revenue share of the antibacterial haemostatic gels market owing to the increasing extensive range of surgical techniques. More than 3 million deaths are caused by unsafe care each year and roughly 1 in every 10 patients suffer harm in healthcare. Up to 4 out of 100 people in low- to middle-income nations pass away in unsafe care. Global health is a key component of global surgery. The study and practice of global surgery aim to increase access to timely, affordable, and high-quality surgical care. It emphasizes strengthening horizontal health systems by addressing a variety of surgical care issues that improve patient outcomes, particularly in underserved populations.
Our in-depth analysis of the global antibacterial haemostatic gels market includes the following segments:
|
Product Type |
|
|
Animal Type |
|
|
End-User Industries |
|
|
Material |
|
|
Application |
|
North American Market Analysis
The antibacterial haemostatic gels market in the North America region will have the biggest growth during the forecast period with a revenue share of around 43%. This growth will be noticed owing to the rising advancement of healthcare infrastructure in this region. In many ways, the US economy is made up of the healthcare sector. It plays a significant role in people's lives by maintaining their well-being and health. Additionally, its budgetary implications and economic size matter. According to the authors 'calculations and the Bureau of Labor Statistics, the healthcare sector now accounts for 24 percent of government spending and employs 11 percent of American workers.
APAC Market Statistics
The antibacterial haemostatic gels market in the Asia Pacific region will also encounter huge growth during the forecast period and will hold the second position owing to the increasing prevalence of chronic disease in this region. The most populated nation, China, is aging at an unprecedented rate. In 2020, about one in five Chinese people was over 60 years of age. By 2050, this figure, which accounts for 25% of the world's older population, is projected to rise to 1 in 3. Globally, older adults are more susceptible to chronic diseases than younger adults, and older adults are the main cause of premature adult deaths.
Pfizer Inc. declared that the European Commission (EC) has accepted marketing permission for the organization’s 20-valent pneumococcal conjugate vaccine, sold in the European Union under the brand name PREVENAR 20®, for active vaccination for the hindrance of invasive disease, pneumonia and keen otitis media affected by Streptococcus pneumoniae in toddlers, kids, and adolescents from 6 weeks to lower than 18 years of age.
Pfizer Inc. the transplant organization, declared a leading existence and the fifth successive year as the Distinguished Founder’s Circle Sponsor for the Annual American Society of Transplant Surgeons (ASTS) Winter Symposium organized on January 11 - 14, 2024 in Miami, Florida.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?